Breaking News Instant updates and real-time market news.

ATHN

athenahealth

$139.93

-1.04 (-0.74%)

06:20
07/31/17
07/31
06:20
07/31/17
06:20

athenahealth downgraded to Market Perform from Outperform at Cowen

ATHN athenahealth
$139.93

-1.04 (-0.74%)

07/24/17
FANA
07/24/17
DOWNGRADE
Target $125
FANA
Underweight
athenahealth downgraded to Underweight from Equal-Weight at First Analysis
First Analysis analyst Frank Sparacino downgraded athenahealth to Underweight while raising his price target for the shares to $125 from $99. The valuation at current share levels is ahead of the underlying fundamentals in the short term, Sparacino tells investors in a research note. He views the risk/reward as unfavorable.
07/24/17
UBSW
07/24/17
NO CHANGE
Target $175
UBSW
Buy
athenahealth price target raised to $175 from $157 at UBS
UBS analyst Michael Cherny raised his price target on athenahealth to $175 from $157 following Q2 results. The analyst noted the company returned to better than expected growth from sequentially better macro trends, growth in hospital business, and the emerging focus on corporate costs, which he sees as a key positive. Cherny reiterated his Buy rating on athenahealth shares.
07/24/17
LEER
07/24/17
NO CHANGE
Target $155
LEER
Market Perform
athenahealth price target raised to $155 from $140 at Leerink
Leerink analyst David Larsen raised his price target for athenahealth to $155 from $140 following earnings. While the analyst is more positive on the stock, the recent rally in his view largely accounts for Elliott Management's involvement and he believes the company is still facing the same industry headwinds that it was facing 3 months ago. Larsen reiterates a Market Perform rating on the shares.
07/24/17
07/24/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Goldman Sachs (GS) downgraded to Neutral from Buy at UBS with analyst Brennan Hawken saying the market seems to be pricing in an inflection in Goldman's trading revenue despite the recent weakness, suggesting a recovery is needed to justify 2018 consensus estimates. 2. Constellation Brands (STZ) downgraded to Neutral from Conviction Buy at Goldman Sachs. 3. Boston Beer (SAM) downgraded to Sell from Neutral at Goldman Sachs with analyst Judy Hong saying she sees further downside risk from weaker volumes and believes 2018 will be another year of volume decline and limited margin offset. 4. athenahealth (ATHN) downgraded to Underweight from Equal-Weight at First Analysis with analyst Frank Sparacino saying the valuation at current share levels is ahead of the underlying fundamentals in the short term. 5. PPG (PPG) was downgraded to Hold from Buy at SunTrust and to Neutral from Buy at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CAFD

8point3 Energy

$14.94

0.04 (0.27%)

, PEGI

Pattern Energy

$22.13

0.14 (0.64%)

15:46
11/20/17
11/20
15:46
11/20/17
15:46
Periodicals
8point3 draws interest from Capital Dynamics, Pattern Energy, Bloomberg says »

Capital Dynamics and…

CAFD

8point3 Energy

$14.94

0.04 (0.27%)

PEGI

Pattern Energy

$22.13

0.14 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

VRX

Valeant

$15.64

0.95 (6.47%)

15:40
11/20/17
11/20
15:40
11/20/17
15:40
Options
Valeant calls active as shares see relative strength »

Valeant calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Jun

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

, GIS

General Mills

$54.23

0.51 (0.95%)

15:34
11/20/17
11/20
15:34
11/20/17
15:34
Periodicals
General Mills, not Nestle, should buy Hain Celestial, Cramer says »

Following a Bloomberg…

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

GIS

General Mills

$54.23

0.51 (0.95%)

NSRGY

Nestle

$85.11

0.7 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$156.55

0.9 (0.58%)

15:34
11/20/17
11/20
15:34
11/20/17
15:34
Options
Intuit options imply 5.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SHPG

Shire

$147.37

2.74 (1.89%)

, RHHBY

Roche

$29.10

0.205 (0.71%)

15:32
11/20/17
11/20
15:32
11/20/17
15:32
Recommendations
Shire, Roche analyst commentary  »

Shire selloff on Roche…

SHPG

Shire

$147.37

2.74 (1.89%)

RHHBY

Roche

$29.10

0.205 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

15:30
11/20/17
11/20
15:30
11/20/17
15:30
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

TWX

Time Warner

$87.93

-0.79 (-0.89%)

15:28
11/20/17
11/20
15:28
11/20/17
15:28
Technical Analysis
Technical View: Time Warner drops on pending antitrust briefing »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$34.74

0.23 (0.67%)

, TWX

Time Warner

$87.93

-0.79 (-0.89%)

15:28
11/20/17
11/20
15:28
11/20/17
15:28
Periodicals
DOJ antitrust announcement concerns AT&T, Time Warner, NBC reports »

Bloomberg also reported…

T

AT&T

$34.74

0.23 (0.67%)

TWX

Time Warner

$87.93

-0.79 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

MRVL

Marvell

$20.29

0.03 (0.15%)

, CAVM

Cavium

$75.83

-0.47 (-0.62%)

15:27
11/20/17
11/20
15:27
11/20/17
15:27
Recommendations
Marvell, Cavium, Broadcom analyst commentary  »

Marvell price target…

MRVL

Marvell

$20.29

0.03 (0.15%)

CAVM

Cavium

$75.83

-0.47 (-0.62%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 06

    Dec

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

15:24
11/20/17
11/20
15:24
11/20/17
15:24
Technical Analysis
Technical View: Hain Celestial spikes higher, retraces some gains »

The shares have come off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

, NSRGY

Nestle

$85.11

0.7 (0.83%)

15:22
11/20/17
11/20
15:22
11/20/17
15:22
Hot Stocks
Hain Celestial surges after report of Nestle weighing potential bid »

Shares of Hain Celestial…

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

NSRGY

Nestle

$85.11

0.7 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$56.11

1.07 (1.94%)

15:20
11/20/17
11/20
15:20
11/20/17
15:20
Options
Sarepta Therapeutics sees a bullish option play »

Sarepta Therapeutics sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

HAIN

Hain Celestial

$40.06

0.21 (0.53%)

15:19
11/20/17
11/20
15:19
11/20/17
15:19
Hot Stocks
Breaking Hot Stocks news story on Hain Celestial »

Hain Celestial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRG

HRG Group

$16.06

-0.025 (-0.16%)

15:19
11/20/17
11/20
15:19
11/20/17
15:19
Options
Harbinger options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

, NSRGY

Nestle

$85.11

0.7 (0.83%)

15:17
11/20/17
11/20
15:17
11/20/17
15:17
Hot Stocks
Breaking Hot Stocks news story on Hain Celestial, Nestle »

Hain Celestial jumps 7%,…

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

NSRGY

Nestle

$85.11

0.7 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:17
11/20/17
11/20
15:17
11/20/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
11/20/17
11/20
15:16
11/20/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$85.11

0.7 (0.83%)

, HAIN

Hain Celestial

$39.84

1.35 (3.51%)

15:16
11/20/17
11/20
15:16
11/20/17
15:16
Periodicals
Breaking Periodicals news story on Nestle, Hain Celestial »

Nestle looking into bid…

NSRGY

Nestle

$85.11

0.7 (0.83%)

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRNCY

Cairn Energy

$5.63

0.3383 (6.39%)

, BP

BP

$39.10

0.01 (0.03%)

15:14
11/20/17
11/20
15:14
11/20/17
15:14
Periodicals
BP in talks to buy 30% SNE field stake from Cairn Energy, Reuters reports »

Cairn Energy (CRNCY) is…

CRNCY

Cairn Energy

$5.63

0.3383 (6.39%)

BP

BP

$39.10

0.01 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$39.98

0.13 (0.33%)

15:14
11/20/17
11/20
15:14
11/20/17
15:14
Hot Stocks
Breaking Hot Stocks news story on Hain Celestial »

Hain Celestial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$34.76

0.25 (0.72%)

, TWX

Time Warner

$88.62

-0.1 (-0.11%)

15:12
11/20/17
11/20
15:12
11/20/17
15:12
Periodicals
U.S. to hold briefing today on 'significant antitrust matter,' Bloomberg says »

Shares of AT&T (T)…

T

AT&T

$34.76

0.25 (0.72%)

TWX

Time Warner

$88.62

-0.1 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

NBRV

Nabriva Therapeutics

$5.80

0.05 (0.87%)

15:10
11/20/17
11/20
15:10
11/20/17
15:10
Options
Notable call buying in Nabriva Therapeutics »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLMN

Bloomin' Brands

$18.27

0.49 (2.76%)

15:07
11/20/17
11/20
15:07
11/20/17
15:07
Hot Stocks
Bloomin' Brands jumps after Jana reports stake, says may push for sale »

Shares of Bloomin'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAME

Atlantic American Corp

$3.60

-0.05 (-1.37%)

15:06
11/20/17
11/20
15:06
11/20/17
15:06
Hot Stocks
Atlantic American Corp names Ross Franklin as CFO »

Atlantic American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$9.24

-0.545 (-5.57%)

15:04
11/20/17
11/20
15:04
11/20/17
15:04
Options
Vipshop options imply 13.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.